Epidemiology and distribution of interstitial lung diseases in Turkey
- PMID: 23711298
- DOI: 10.1111/crj.12035
Epidemiology and distribution of interstitial lung diseases in Turkey
Abstract
Introduction: There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients.
Objective: The goal of this study was to evaluate the epidemiological features of ILD in Turkey.
Methods: Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study.
Results: The mean age was 51.8 ± 16.7 years. The mean age among males was 50.5 ± 18.6 years and 53.0 ± 14.6 years among females (P < 0.001). 23.8% of the cases had ILD with known causes, while 39.4% were in granulomatous group, 23.7% were idiopathic, and 4.4% were in the unclassified group. Overall, histopathologically confirmed diagnosis rate was 40.4%. Sarcoidosis was the most common disease (37%), whereas cases with idiopathic pulmonary fibrosis (IPF) constituted 19,9% of patients. 53% of the sarcoidosis patients were females, and the ratio reaches to 75% under 50 years of age (for this group, IPF ratio is %3). In contrast, sarcoidosis and IPF ratios were equal in males (25%). Sarcoidosis was 8% in men over 50, while IPF was %45.
Conclusion: The overall incidence of ILD in Turkey was computed to be 25.8/100,000.
Keywords: distribution; epidemiology; incidence; interstitial lung diseases.
© 2013 John Wiley & Sons Ltd.
Similar articles
-
Interstitial Lung Diseases in Developing Countries.Ann Glob Health. 2019 Jan 22;85(1):4. doi: 10.5334/aogh.2414. Ann Glob Health. 2019. PMID: 30741505 Free PMC article. Review.
-
A cohort study of interstitial lung diseases in central Denmark.Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20. Respir Med. 2014. PMID: 24636811
-
[Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].Pneumonol Alergol Pol. 2012;80(6):523-32. Pneumonol Alergol Pol. 2012. PMID: 23109204 Polish.
-
Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.Respirology. 2013 Nov;18(8):1191-6. doi: 10.1111/resp.12154. Respirology. 2013. PMID: 23819865
-
Interstitial lung disease evaluation: detecting connective tissue disease.Respiration. 2015;90(3):177-84. doi: 10.1159/000440665. Epub 2015 Sep 8. Respiration. 2015. PMID: 26343272 Review.
Cited by
-
Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis.Balkan Med J. 2023 Jan 23;40(1):34-39. doi: 10.4274/balkanmedj.galenos.2022.2022-8-64. Epub 2022 Dec 9. Balkan Med J. 2023. PMID: 36484365 Free PMC article.
-
Interstitial Lung Diseases in Developing Countries.Ann Glob Health. 2019 Jan 22;85(1):4. doi: 10.5334/aogh.2414. Ann Glob Health. 2019. PMID: 30741505 Free PMC article. Review.
-
The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis.Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024015. doi: 10.36141/svdld.v41i2.15454. Sarcoidosis Vasc Diffuse Lung Dis. 2024. PMID: 38940711 Free PMC article.
-
MicroRNAs as potential targets for progressive pulmonary fibrosis.Front Pharmacol. 2015 Nov 5;6:254. doi: 10.3389/fphar.2015.00254. eCollection 2015. Front Pharmacol. 2015. PMID: 26594173 Free PMC article. Review.
-
Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis.Eurasian J Med. 2017 Oct;49(3):161-166. doi: 10.5152/eurasianjmed.2017.17181. Eurasian J Med. 2017. PMID: 29123437 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical